Other

Novartis profit up as world flocks to buy medecine

Swiss pharma giant Novartis on Tuesday reported higher profits for the first quarter as customers rushing to buy treatments during the coronavirus outbreak boosted the bottom line.

Medical economics

Profits jab higher at insulin maker Novo Nordisk

Novo Nordisk said Friday that its new treatment for adults who suffer from diabetes drove sales and profits higher, but the world's top manufacturer of insulin still faced difficulties in the key US market.

Diseases, Conditions, Syndromes

Likelihood of transplant lower at profit-driven dialysis facilities

(HealthDay)—Patients with end-stage kidney disease who undergo dialysis at for-profit institutions are less likely to receive a kidney transplant, according to a study published online Sept. 10 in the Journal of the American ...

Other

Drugmaker Novo Nordisk profits jump in diabetes scourge

Danish drugmaker Novo Nordisk, the world's leading insulin provider, on Wednesday reported a six percent jump in net profit in the first quarter, as the global onslaught of diabetes continued to grow.

page 3 from 11